Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine or hydroxychloroquine use and protection against COVID-19 in patients with rheumatic diseases
RBR-9ktwx6Recruiting
- Sponsor
- Sociedade Brasileira de Reumatologia
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Sociedade Brasileira de Reumatologia. Started Mar 2020; status: recruiting.
02
Drugs
chloroquinehydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-9ktwx6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9ktwx6.